Mutations in the major carnitine transporter, encoded by the SLC22A5 gene [also known as zwitterion/cation transporter 2 (OCTN2)], are the predominant causes of primary carnitine deficiency
The longer, more useful answer is what were here to explore
GLP-1 medications offer a scientifically-backed alternative, providing benefits such as: Sustained Weight Loss: Clinical studies have shown that GLP-1 therapies can lead to significant and sustainable weight loss
Ann Rheum Dis (2003) 62(2):16871
If you think you might benefit from compounded semaglutide with vitamin B12, consult with a healthcare professional to discuss the potential benefits and risks.
Aging consistently amplifies susceptibility to systemic amyloidosesincluding AL, AA, ATTR, ALECT2, hereditary formsand to age-related protein-aggregation diseases such as cataract